United Therapeutics Corporation Strong Buy: phase 3 Tyvaso wins in IPF boost FVC, support summer sNDA and Priority Review ...
StockStory.org on MSN
Why United Therapeutics (UTHR) stock is up today
What Happened? Shares of biotechnology company United Therapeutics (NASDAQ:UTHR) jumped 12.7% in the afternoon session after ...
Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with ...
Preclinical data indicate that inhaled treprostinil may be useful for the treatment of idiopathic pulmonary fibrosis (IPF) through an antifibrotic mechanism, a premise that is supported by clinical ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 30, 2026--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that its TETON-1 study evaluating the ...
Credit: Boehringer Ingelheim. Nerandomilast reduces the expression of pro-fibrotic growth factors and inflammatory cytokines, commonly overexpressed in IPF. Findings showed nerandomilast led to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results